Design of the first animal model of spontaneous atherothrombotic occlusion due to plaque erosion Dec. 2, 2013
EN-3356, a novel CYP17A inhibitor for the treatment of castration-resistant prostate cancer Nov. 29, 2013
Characterization of a third-generation tyrosine kinase inhibitor to overcome cancer drug resistance Nov. 29, 2013
Ugimers as novel antisense drugs with improved solubility and cell wall penetration properties Nov. 29, 2013
Aurora kinase A inhibitor synergized with taxanes for the treatment of drug-resistant cancers Nov. 28, 2013
RSS